榮豐控股(000668.SZ):7.87億收購湖南威宇100%股權 提升管理效率、優化資源配置
格隆匯9月15日丨榮豐控股(000668.SZ)公佈,於2022年9月14日,公司與控股子公司安徽威宇醫療器械科技有限公司(簡稱“威宇醫療”)簽署《股權轉讓協議》,受讓其持有的湖南威宇醫藥有限公司(簡稱“湖南威宇”或“標的公司”)100%股權,交易對價為7.87億元。
標的公司於2022年8月3日成立,註冊資本5000萬元,法定代表人寧湧超;成立目的主要為整合上市公司擬購買的威宇醫療下屬公司。湖南威宇成立後,威宇醫療將12家子公司,7家孫公司裝入標的公司。
該次股權受讓完成後,湖南威宇將成為上市公司全資子公司,該次交易屬於公司與控股子公司之間的交易,不會導致公司合併報表範圍發生變化。
公司表示,通過該次收購有利於公司加強對標的公司及其下屬公司的控制,提升管理效率,優化資源配置,有利於加快公司主營業務發展,符合公司的長遠規劃及發展戰略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.